Financials of Biocon Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Biocon Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +3,7743,4233,4623,9543,9173,4333,5903,8214,4173,9424,2964,1734,517
Expenses +2,8172,7412,7453,0513,0042,8122,9053,0703,3393,1933,4603,3403,496
Operating Profit9576817179039136206857521,0787498358341,020
OPM %25%20%21%23%23%18%19%20%24%19%19%20%23%
Other Income +15294134587401,1665853578081-176-28
Interest249233248267227236226223212277272210232
Depreciation364358389414407405420425436455473515513
Profit before tax4971842148083191,1469815648797171-68248
Tax %17%19%19%7%30%25%72%48%6%8%22%-24%20%
Net Profit +414149173753223862278145989133-52199
EPS in Rs2.610.841.055.501.135.49-0.130.212.870.230.631.080.78

Financials of Biocon Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +3,0903,3473,8914,1235,5146,3007,1438,18411,17414,75615,26216,927
Expenses +2,3942,9572,9123,2944,1214,6965,5626,3918,76211,54012,00813,472
Operating Profit6963909808291,3941,6041,5811,7932,4123,2163,2543,455
OPM %23%12%25%20%25%25%22%22%22%22%21%20%
Other Income +15863917322834019926072188531,217-60
Interest929266271655868419974897990
Depreciation2212492773854485527158141,1131,5691,6871,957
Profit before tax6247518506101,2151,1861,0689838971,5251,887448
Tax %15%19%19%26%17%27%21%22%28%15%24%18%
Net Profit +5286096884531,0038718467726431,2981,429369
EPS in Rs4.144.595.103.107.546.246.175.403.858.528.442.38
Dividend Payout %20%18%10%16%7%0%0%9%39%6%6%21%

Financials of Biocon Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital100100100300300600600600600600600810
Reserves3,1713,9344,7384,8815,7986,1067,0277,83217,26719,18321,04433,221
Borrowings +1,1172,4782,3022,2642,4222,7154,4815,14718,01916,27718,36215,434
Other Liabilities +1,9881,9472,2542,5453,6724,9936,3826,76315,85619,69318,53414,185
Total Liabilities6,3758,4589,3949,99012,19214,41418,49020,34251,74255,75358,54063,651
Fixed Assets +1,6301,7483,6263,7004,4715,9716,3646,56929,46830,64431,96338,860
CWIP1,6772,2408391,3031,8992,1962,8004,1107,3177,9938,5084,613
Investments2309021,2536751,0129661,9521,5882,0691,0001,1271,779
Other Assets +2,8393,5693,6764,3124,8115,2817,3748,07412,88816,11716,94118,399
Total Assets6,3758,4589,3949,99012,19214,41418,49020,34251,74255,75358,54063,651

Financials of Biocon Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +2113716406621,1551,2831,1601,1771,8522,9544,0611,994
Cash from Investing Activity +-491-1,138-510-684-703-1,505-3,651-1,662-14,260-1,002-203-2,082
Cash from Financing Activity +1861,068-178-240-2423882,56424213,049-2,333-1,854-924
Net Cash Flow-94300-47-26121016572-243641-3802,004-1,012
Free Cash Flow-627-24632-251-337-546-577-7461291,0461,71882
CFO/OP49%158%86%104%104%101%86%80%86%101%139%65%

Financials of Biocon Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days9178839486717792117154131129
Inventory Days132153160161199263304309423368346390
Days Payable125172187224231243246216383467460434
Cash Conversion Cycle985957315391134184157551885
Working Capital Days-19-12246-2-318713-68-63-2
ROCE %12%9%12%8%13%13%10%9%6%6%6%4%